Since adipocyte apoptosis is a key initial contributor to macrophage infiltration into AT (196), the inhibition of adipocyte apoptosis using adiponectin may have therapeutic potential in treating obesity-associated metabolic disorders. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.